Carl M. Fletcher

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial.

Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial.

Journal: The Lancet. Infectious diseases
Published: September 02, 2025

Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial.

Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial.

Journal: The Lancet. Infectious diseases
Published: September 02, 2025

Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/ml and history of K103N mutation.

Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/ml and history of K103N mutation.

Journal: AIDS (London, England)
Published: July 31, 2025

Effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV: Data from the COMBINE-2 study.

Effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV: Data from the COMBINE-2 study.

Journal: HIV medicine
Published: May 04, 2025

Morbidity and risk factors of COVID-19 in people with HIV-1 in Europe: A combined observational cohort and nested case-control study.

Morbidity and risk factors of COVID-19 in people with HIV-1 in Europe: A combined observational cohort and nested case-control study.

Journal: HIV medicine
Published: March 30, 2025

Use of doravirine-based regimens in clinical practice in Europe.

Use of doravirine-based regimens in clinical practice in Europe.

Journal: AIDS (London, England)
Published: November 13, 2024

Do hallucinations exist on a continuum with subclinical hallucinatory experiences? A multi-method taxometric study.

Do hallucinations exist on a continuum with subclinical hallucinatory experiences? A multi-method taxometric study.

Journal: Schizophrenia research
Published: October 25, 2024

Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial.

Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial.

Journal: The lancet. HIV
Published: May 09, 2023

Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19.

Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19.

Journal: Infectious diseases now
Published: December 20, 2022

Explosive detection using a novel dielectric barrier discharge ionisation source for mass spectrometry.

Explosive detection using a novel dielectric barrier discharge ionisation source for mass spectrometry.

Journal: Journal of mass spectrometry : JMS
Published: September 28, 2017

Current Practices in Choosing Estimands and Sensitivity Analyses in Clinical Trials: Results of the ICH E9 Survey.

Current Practices in Choosing Estimands and Sensitivity Analyses in Clinical Trials: Results of the ICH E9 Survey.

Journal: Therapeutic innovation & regulatory science
Published: January 01, 2017

Rapid identification of seized controlled substances and related compounds by tandem mass spectrometry without chromatography.

Rapid identification of seized controlled substances and related compounds by tandem mass spectrometry without chromatography.

Journal: Rapid communications in mass spectrometry : RCM
Published: October 30, 2015
Showing 1-12 of 12

Last Updated: 09/26/2026